Targeted nutrition
Supporting metabolic stability in clinical care requires energy provision alongside consideration of postprandial glucose and insulin responses. Isomaltulose is a fully digestible carbohydrate providing 4 kcal/g, but it is digested more slowly than sucrose or maltodextrin.
This results in a lower and more sustained postprandial blood glucose response and a reduced insulin response, making isomaltulose relevant for specialized nutrition products where controlled carbohydrate delivery is desired.
At a glance
- Targeted nutrition often requires energy provision with controlled metabolic responses
- Isomaltulose is fully digestible and provides 4 kcal/g
- It delivers glucose more gradually than rapidly available carbohydrates
- It supports lower postprandial blood glucose and insulin responses
- It can be used in specialized nutrition formulations designed for glycemic management
Explore further:
Role in specialized nutrition products
The role of carbohydrate quality in specialized nutrition products is particularly relevant when postprandial glycemic response needs to be considered alongside energy delivery.
Isomaltulose provides fully available carbohydrate energy while producing a lower and more sustained glycemic response than rapidly available carbohydrates. This makes it suitable for formulations designed for controlled carbohydrate delivery.
Applications in clinical nutrition
Applications of isomaltulose in clinical nutrition may include diabetes-specific oral nutrition supplements, enteral nutrition formulas, and specialized nutrition products designed for glycemic management or metabolic risk. In these formulations, isomaltulose can contribute fully available carbohydrate energy while supporting a lower postprandial glycemic response.
Practical considerations
Clinical nutrition formulations must be adapted to the patient population, medical condition, nutritional requirements, route of administration, and complete nutrient profile. For people with diabetes or other metabolic conditions, carbohydrate intake and glycemic management should remain part of individualized clinical care.
Conclusion
In clinical nutrition, carbohydrate quality influences both energy delivery and postprandial metabolic response. Isomaltulose is a fully digestible, slow-release carbohydrate that provides fully available energy while supporting lower postprandial glucose and insulin responses than rapidly available carbohydrates. This makes it a practical carbohydrate option for specialized nutrition products where controlled glycemic response is an important formulation goal.
Diabetes
Supporting glycemic control in diabetes requires attention to both carbohydrate quantity and carbohydrate quality. Because glucose regulation and insulin action are impaired in diabetes, postprandial blood glucose is an important consideration in dietary management.
Slowly digestible carbohydrates such as isomaltulose, with a glycemic index of approximately 32, release glucose more gradually and can help moderate postprandial glucose and insulin responses compared with rapidly available carbohydrates. Studies have also reported differences in incretin responses, reflecting its slower digestion and absorption.
Glycemic response and metabolic control
Glycemic response and metabolic control in diabetes are influenced by the rate at which carbohydrate is digested and absorbed. Rapidly available carbohydrates can produce pronounced postprandial glucose excursions. Isomaltulose has a glycemic index of approximately 32 and is digested more slowly than sucrose, resulting in a lower and more sustained postprandial blood glucose response in people with diabetes.
Insulin demand and metabolic stability
Insulin demand and metabolic stability are also influenced by carbohydrate quality. The slower glucose release from isomaltulose results in a lower postprandial insulin response compared with rapidly available carbohydrates. This may be particularly relevant where insulin resistance or impaired insulin secretion affects postprandial glucose regulation.
Incretin response and glucose regulation
Incretin response and glucose regulation can also be influenced by the rate and location of carbohydrate absorption. Human studies in people with type 2 diabetes have shown higher GLP-1 and lower GIP responses after isomaltulose compared with sucrose. These hormonal responses complement the lower postprandial glucose and insulin profile of isomaltulose.
Practical considerations
Diabetes nutrition requires individualized planning that integrates carbohydrate intake, meal timing, medication, physical activity, glucose monitoring, and personal glycemic goals. Isomaltulose can be incorporated into foods, beverages, or meal plans designed for a lower postprandial glycemic response, while still contributing fully digestible carbohydrate energy.
Conclusion
Diabetes nutrition requires attention to both the amount and quality of carbohydrate consumed. Isomaltulose is a fully digestible, low-glycemic carbohydrate that produces lower and more sustained postprandial blood glucose and insulin responses than rapidly available carbohydrates. These properties make it relevant within individualized dietary strategies for glycemic management.
Metabolic syndrome
Addressing metabolic risk in metabolic syndrome requires consideration of insulin resistance, glucose regulation, abdominal adiposity, blood lipids, and blood pressure.
Carbohydrate quality is relevant because it influences postprandial glucose and insulin responses. Isomaltulose provides glucose more gradually than rapidly available carbohydrates, resulting in lower postprandial glucose and insulin responses. Greater fat oxidation has also been observed in people with metabolic syndrome, making isomaltulose a relevant carbohydrate option within broader dietary and lifestyle strategies.
Insulin resistance and glycemic control
Insulin resistance and glycemic control are central to metabolic syndrome. When insulin sensitivity is reduced, postprandial glucose and insulin responses can become more pronounced. Isomaltulose is digested more slowly than rapidly available carbohydrates, resulting in lower and more sustained postprandial blood glucose and insulin responses.
Fat oxidation and metabolic flexibility
Fat oxidation and metabolic flexibility are influenced by insulin. Higher postprandial insulin concentrations suppress fat oxidation, whereas the lower insulin response to isomaltulose can favor greater use of fat as an energy source. Human studies in people with overweight or metabolic syndrome have demonstrated higher fat oxidation after isomaltulose compared with higher-glycemic carbohydrates.
Glycemic variability and cardiometabolic risk
Glycemic variability describes fluctuations in blood glucose over time and is relevant to cardiometabolic health. Diets incorporating isomaltulose have been associated with lower glycemic response and reduced glycemic variability compared with higher-glycemic dietary patterns. These findings support the relevance of carbohydrate quality in dietary strategies for metabolic syndrome.
Incretin response and metabolic signaling
Incretin response and metabolic signaling are also influenced by carbohydrate digestion. Isomaltulose has been associated with higher GLP-1 and lower GIP responses than sucrose in human studies. These hormonal differences contribute to the distinct postprandial metabolic profile of isomaltulose.
Practical considerations
Management of metabolic syndrome requires a comprehensive approach including diet quality, physical activity, weight management where appropriate, and clinical care. Within this broader strategy, replacing rapidly available carbohydrates with slower-release options such as isomaltulose can improve carbohydrate quality and moderate postprandial glucose and insulin responses.
Conclusion
Metabolic syndrome involves interconnected abnormalities in glucose regulation, insulin sensitivity, lipid metabolism, body composition, and blood pressure. Isomaltulose provides lower and more sustained postprandial glucose and insulin responses and has been associated with greater fat oxidation and lower glycemic variability in relevant study populations. These characteristics make it a useful carbohydrate option within comprehensive dietary strategies for metabolic health.
Overweight and obesity
Postprandial glucose and insulin response
Postprandial glucose and insulin responses can be more pronounced when insulin sensitivity is reduced. Isomaltulose is digested more slowly than rapidly available carbohydrates, resulting in lower and more sustained postprandial blood glucose and insulin responses. This metabolic profile can be relevant within dietary strategies focused on carbohydrate quality and weight management.
Fat oxidation and metabolic flexibility
Conclusion
Etiam ultricies nisi vel augue. Curabitur ullamcorper ultricies nisi. Nam eget dui. Etiam rhoncus. Maecenas tempus, tellus eget condimentum rhoncus, sem quam semper libero, sit amet adipiscing sem neque sed ipsum. Nam quam nunc, blandit vel, luctus pulvinar, hendrerit id, lorem. Maecenas nec odio et ante tincidunt tempus.
Etiam sit amet orci eget eros faucibus tincidunt. Duis leo. Sed fringilla mauris sit amet nibh. Donec sodales sagittis magna. Sed consequat, leo eget bibendum sodales, augue velit cursus nunc,
References
Alish CJ, Garvey WT, Maki KC, Sacks GS, Hustead DS, Hegazi RA, Mustad VA (2010) A diabetes-specific enteral formula improves glycemic variability in patients with type 2 diabetes. Diabetes Technol.Ther. 12(6):419–425. https://www.ncbi.nlm.nih.gov/pubmed/20470226 [Accessed 8 September 2017]
Ang M, Linn T (2014) Comparison of the effects of slowly and rapidly absorbed carbohydrates on postprandial glucose metabolism in type 2 diabetes mellitus patients: a randomized trial. American Journal of Clinical Nutrition 100(4):1059-1068.
Brunner S, Holub I, Theis S et al. (2012) Metabolic effects of replacing sucrose by isomaltulose in subjects with type 2 diabetes: a randomized double-blind trial. Diabetes Care 35(6):1249-1251.
Henry CJ, Kaur B, Quek RYC et al. (2017) A low glycemic index diet incorporating isomaltulose is associated with lower glycemic response and variability, and promotes fat oxidation. Nutrients 9(5):473.
Holub I, Gostner A, Theis S et al. (2010) Novel findings on the metabolic effects of the low glycemic carbohydrate isomaltulose (Palatinose™). British Journal of Nutrition 103(12):1730-1737.
Keyhani-Nejad F, Kemper M, Schueler R et al. (2016) Effects of palatinose and sucrose intake on glucose metabolism and incretin secretion in subjects with type 2 diabetes. Diabetes Care 39(3):e38-e39. doi:10.2337/dc15-1891. Maresch CC, Petry SF, Theis S et al. (2017) Low glycemic index prototype isomaltulose: update of clinical trials. Nutrients 9(4):381
König D, Theis S, Kozianowski G et al. (2012) Postprandial substrate use in overweight subjects with metabolic syndrome after isomaltulose ingestion. Nutrition 28(6):651-656.
Tey SL, van Helvoort A, Henry CJ (2016) Glycaemic responses to liquid food supplements among three Asian ethnic groups. Eur J Nutr 55(8):2493–2498. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122616/
Vanschoonbeek K, Lansink M, van Laere K et al. (2009) Slowly digestible carbohydrate sources can be used to attenuate the postprandial glycemic response to the ingestion of diabetes-specific enteral formulas. Diabetes Educator 35:631-640.
Xie J, Li J, Qin Q et al. (2022) Effect of isomaltulose on glycemic and insulinemic responses: a systematic review and meta-analysis of randomized controlled trials. Advances in Nutrition 13(5):1774-1785. doi:10.1093/advances/nmac057.